Thermo Fisher extends its diagnostics reach, shares supported by strong S&P 500 positioning

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 14:12.

Thermo Fisher Scientific (US8835561023) stands as one of the larger health care names in the S&P 500, with a market capitalization around 190.7 billion dollars and a NASDAQ listing under the ticker TMO. The stock closed at 513.20 dollars on NASDAQ on June 26, 2026 according to TradingKey.

What recent data show

Thermo Fisher shares closed at 513.20 dollars on June 26, 2026, up 1.47 percent for the session according to TradingKey. That source also reports a trailing price-earnings ratio of 28.15 times and earnings per share of 17.78 dollars for Thermo Fisher.

Analyst data compiled by TradingKey point to an overall Buy rating on Thermo Fisher, with a consensus price target of 602.87 dollars. This implies a double-digit percentage upside from the latest closing price and underlines a supportive long-term stance by covering analysts.

Analyst view and sector context

The company operates in the health care and life sciences tools segment, alongside peers such as Danaher and Agilent Technologies, serving pharmaceutical and research customers globally. The S&P 500 membership anchors Thermo Fisher within major U.S. equity benchmarks watched by institutional investors.

With a broad product and service portfolio, Thermo Fisher benefits from diversified exposure to diagnostics, research tools and bioprocessing, areas supported by steady demand from laboratories and biopharma companies. The Buy consensus and elevated price target reflect the expectation that this positioning can support continued earnings generation.

The business behind the stock

Thermo Fisher Scientific generates revenue primarily by providing analytical instruments, laboratory equipment, reagents and consumables to research laboratories, pharmaceutical companies and clinical diagnostics providers. The company also offers contract development and manufacturing services for biologic therapies, which brings in recurring service revenue from biopharmaceutical clients.

Where the stock trades today

The Thermo Fisher shares (US8835561023) trade on NASDAQ under the ticker TMO and closed on 2026-06-26 at 513.20 dollars. That closing level reflects a market capitalization of around 190.7 billion dollars for the company on the same date.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell securities. All data are based on sources considered reliable but cannot be guaranteed.